MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SXTP made $437,602 in revenue. -$2,316,324 in net income. Net profit margin of -529.32%.

Income Overview

Revenue
$437,602
Net Income
-$2,316,324
Net Profit Margin
-529.32%
EPS
-$0.66
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Product revenues net of discounts and rebates
437,602 100,932 163,552 173,654.5
Cost of revenues
537,690 50,051 73,272 91,757
Gross (loss) profit
-100,088 50,881 90,280 81,897.5
Research revenues
90,960 206,939 92,731 4,821.167
Net (loss) revenue
-9,128 257,820 183,011 86,718.667
Research and development
809,777 249,884 407,622 475,568.5
General and administrative expenses
1,506,620 1,612,764 1,686,264 1,340,186
Total operating expenses
2,316,397 1,862,648 2,093,886 1,815,754.5
Loss from operations
-2,325,525 -1,604,828 -1,910,875 -1,703,744.5
Interest expense
1,708 1,221 1,790 1,978
Change in fair value of derivative liabilities
21,103 140,447 -5,105 36,685
Other income, net
31,550 13,066 30,322 25,366
Total interest and other income (expense), net
8,739 -128,602 33,637 893,056
Loss from operations before provision for income taxes
-2,316,786 -1,733,430 -1,877,238 -810,688.5
Provision for income taxes (note 9)
250 1,500 63 -219
Net loss
-2,317,036 -1,734,930 -1,877,301 -810,469.5
Net loss noncontrolling interest
-712 -1,204 -752 -3,186
Net loss attributed to 60 degrees pharmaceuticals, inc
-2,316,324 -1,733,726 -1,876,549 -807,283.5
Cumulative dividends on series a preferred stock
--118,158 124,424.5
Unrealized foreign currency translation loss
---9,904 -3,815
Net (loss) income - attributed to common stockholders
---2,004,611 -935,523
Basic (in dollars per share)
-0.66 -1.25 -1.56 -6.695
Basic (in shares)
3,675,407 1,472,891 1,283,462 -1,501,697.5
Diluted (in dollars per share)
-0.66 -1.25 -1.56 -6.695
Diluted (in shares)
3,675,407 1,472,891 1,283,462 -1,501,697.5
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss attributedto 60 degrees...-$2,316,324 Net loss noncontrolling interest-$712 Net loss-$2,317,036 Other income, net$31,550 Provision for income taxes(note 9)$250 Loss from operationsbefore provision for...-$2,316,786 Total interest andother income...$8,739 Change in fair value ofderivative liabilities$21,103 Interest expense$1,708 Loss from operations-$2,325,525 Total operatingexpenses$2,316,397 Net (loss) revenue-$9,128 Research revenues$90,960 General andadministrative expenses$1,506,620 Research and development$809,777 Gross (loss) profit-$100,088 Product revenues net ofdiscounts and rebates$437,602 Cost of revenues$537,690

60 DEGREES PHARMACEUTICALS, INC. (SXTP)

60 DEGREES PHARMACEUTICALS, INC. (SXTP)